Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America

Publication date: October 2020Source: Multiple Sclerosis and Related Disorders, Volume 45Author(s): Richard K Burt, Paul Tappenden, Xiaoqiang Han, Kathleen Quigley, Indira Arnautovic, Basil Sharrack, John A Snowden, Daniel Hartung
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research